Search results: Sage Journals

Open accessCase reportFirst published 2022

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy

Kamilya A. Schumacher, Aidar R. Gosmanov

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published July, 2024

Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists

Kyriakos Kintzoglanakis, Christos Diamantis, Anargiros Mariolis [...]

Diabetes & Vascular Disease Research

Restricted accessResearch articleFirst published 2026

MiniMed TM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics

Aikaterini Kountouri, Ignatios Ikonomidis, Konstantinos Katogiannis [...]

Diabetes Technology & Therapeutics

Restricted accessReview articleFirst published November, 2023

Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Judy W. M. Cheng, Vincent Colucci, James S. Kalus [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2022

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past,present and future

Ritwika Mallik, Tahseen A. Chowdhury

Therapeutic Advances in Endocrinology and Metabolism

Open accessResearch articleFirst published August 18, 2020

Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years

Juraj Secnik, Hong Xu, Emilia Schwertner [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published March 8, 2022

Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia

Juraj Secnik, Hong Xu, Emilia Schwertner [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published 2026

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors,Glucagon-Like Peptide-1 Receptor Agonists,and Sodium–Glucose Cotransporter-2 Inhibitors as Adjunctive Therapy to Automated Insulin Delivery System in Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Yongwen Zhou, Mengyun Lei, Qiongyan Lin [...]

Diabetes Technology & Therapeutics

Open accessResearch articleFirst published 2025

Real-world evidence on the association of novel antidiabetic medication use with cancer risk and protective effects: a systematic review and network meta-analysis

Ahmed S. Kenawy, Yi-Shao Liu, Ayobami Aiyeolemi [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published July, 2023

Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis

Kegang Zhan, Liuqi Weng, Li Qi [...]

Annals of Pharmacotherapy

Open accessCase reportFirst published 2022

Hemochromatosis Gene Mutation in Persons Developing Erythrocytosis on Combined Testosterone and SGLT-2 Inhibitor Therapy

Kamilya A. Schumacher, Aidar R. Gosmanov

Journal of Investigative Medicine High Impact Case Reports

Open accessResearch articleFirst published July, 2024

Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists

Kyriakos Kintzoglanakis, Christos Diamantis, Anargiros Mariolis [...]

Diabetes & Vascular Disease Research

Restricted accessResearch articleFirst published 2026

MiniMed TM 780G Hybrid Closed-Loop Systems Improves Markers of Vascular and Endothelial Function in Patients with Type 1 Diabetes: Association with Continuous Glucose Monitoring Metrics

Aikaterini Kountouri, Ignatios Ikonomidis, Konstantinos Katogiannis [...]

Diabetes Technology & Therapeutics

Restricted accessReview articleFirst published November, 2023

Sodium-Glucose Cotransporter 2 Inhibitors Among Heart Failure With Mildly Reduced and Preserved Ejection Fraction

Judy W. M. Cheng, Vincent Colucci, James S. Kalus [...]

Annals of Pharmacotherapy

Open accessReview articleFirst published 2022

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past,present and future

Ritwika Mallik, Tahseen A. Chowdhury

Therapeutic Advances in Endocrinology and Metabolism

Open accessResearch articleFirst published August 18, 2020

Dementia Diagnosis Is Associated with Changes in Antidiabetic Drug Prescription: An Open-Cohort Study of ∼130,000 Swedish Subjects over 14 Years

Juraj Secnik, Hong Xu, Emilia Schwertner [...]

Journal of Alzheimer’s Disease

Open accessResearch articleFirst published March 8, 2022

Glucose-Lowering Medications and Post-Dementia Survival in Patients with Diabetes and Dementia

Juraj Secnik, Hong Xu, Emilia Schwertner [...]

Journal of Alzheimer’s Disease

Restricted accessResearch articleFirst published 2026

Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors,Glucagon-Like Peptide-1 Receptor Agonists,and Sodium–Glucose Cotransporter-2 Inhibitors as Adjunctive Therapy to Automated Insulin Delivery System in Type 1 Diabetes: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Yongwen Zhou, Mengyun Lei, Qiongyan Lin [...]

Diabetes Technology & Therapeutics

Open accessResearch articleFirst published 2025

Real-world evidence on the association of novel antidiabetic medication use with cancer risk and protective effects: a systematic review and network meta-analysis

Ahmed S. Kenawy, Yi-Shao Liu, Ayobami Aiyeolemi [...]

Therapeutic Advances in Drug Safety

Restricted accessResearch articleFirst published July, 2023

Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis

Kegang Zhan, Liuqi Weng, Li Qi [...]

Annals of Pharmacotherapy